Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigens

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chen, Hong Sen ^a   Hou, Shin Chen ^a   Jian, Jhih Wei ^a,b,c   Goh, King Siang ^a   Shen, San Tai ^a   Lee, Yu Ching ^a   You, Jhong Jhe ^a   Peng, Hung Pin ^a   Kuo, Wen Chih ^d   Chen, Shui Tsung ^d   Peng, Ming Chi ^d   Wang, Andrew H J ^d   Yu, Chung Ming ^a   Chen, Ing Chien ^a   Tung, Chao Ping ^a   Chen, Tzu Han ^a   Ping Chiu, Kuo ^a   Ma, Che ^a   Yuan Wu, Chih ^a   Lin, Sheng Wei ^d   Yang, An Suei ^a   more..

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF INFORMATION SCIENCE   (Taiwan)

^d INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN ANTIBODY REACTION; BINDING SITE; CHEMISTRY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MOLECULAR GENETICS; MOUSE; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-ANTIBODY REACTIONS; BINDING SITES; HUMANS; IMMUNITY, INNATE; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTOR, ERBB-2; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84937876252     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12411     Document Type: Article

References (47)

1. Franklin, M. C. et al. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5, 317-328 (2004).
2. Cho, H. S. et al. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421, 756-760 (2003).
3. Berzofsky, J. A. Intrinsic and extrinsic factors in protein antigenic structure. Science 229, 932-940 (1985).
4. Benjamin, D. C. et al. The antigenic structure of proteins: a reappraisal. Annu Rev Immunol 2, 67-101 (1984).
5. Peng, H. P., Lee, K. H., Jian, J. W. , Yang, A. S. Origins of specificity and affinity in antibody-protein interactions. Proc Natl Acad Sci USA 111, E2656-2665 (2014).
6. Weinstein, J. A., Jiang, N., White, R. A., 3rd, Fisher, D. S. , Quake, S. R. High-throughput sequencing of the zebrafish antibody repertoire. Science 324, 807-810 (2009).
7. Schroeder, H. W., Jr. Similarity and divergence in the development and expression of the mouse and human antibody repertoires. Dev Comp Immunol 30, 119-135 (2006).
8. Di Noia, J. M. , Neuberger, M. S. Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 76, 1-22 (2007).
9. Eisen, H. N. Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses. Cancer Immunol Res 2, 381-392 (2014).
10. Victora, G. D. , Nussenzweig, M. C. Germinal centers. Annu Rev Immunol 30, 429-457 (2012).
11. Wu, X. et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333, 1593-1602 (2011).
12. Robert, R. et al. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid beta peptide. Mol Immunol 48, 59-72 (2010).
13. Pappas, L. et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516, 418-422 (2014).
14. Avnir, Y. et al. Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. PLoS Pathog 10, e1004103 (2014).
15. Lloyd, C. et al. Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel 22, 159-168 (2009).
16. Zhai, W. et al. Synthetic antibodies designed on natural sequence landscapes. J Mol Biol 412, 55-71 (2011).
17. Georgiou, G. et al. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol 32, 158-168 (2014).
18. Finn, J. A. , Crowe, J. E., Jr. Impact of new sequencing technologies on studies of the human B cell repertoire. Curr Opin Immunol 25, 613-618 (2013).
19. Galson, J. D., Pollard, A. J., Truck, J. , Kelly, D. F. Studying the antibody repertoire after vaccination: practical applications. Trends Immunol 35, 319-331 (2014).
20. Mathonet, P. , Ullman, C. G. The application of next generation sequencing to the understanding of antibody repertoires. Front Immunol 4, 265 (2013).
21. Reddy, S. T. et al. Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat Biotechnol 28, 965-969 (2010).
22. Laserson, U. et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci USA 111, 4928-4933 (2014).
23. Adams, J. J., Nelson, B. , Sidhu, S. S. Recombinant genetic libraries and human monoclonal antibodies. Methods Mol Biol 1060, 149-170 (2014).
24. Tiller, T. et al. A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties. MAbs 5, 445-470 (2013).
25. Mahon, C. M. et al. Comprehensive Interrogation of a Minimalist Synthetic CDR-H3 Library and Its Ability to Generate Antibodies with Therapeutic Potential. J Mol Biol 425, 1712-1730 (2013).
26. Miersch, S. , Sidhu, S. S. Synthetic antibodies: concepts, potential and practical considerations. Methods 57, 486-498 (2012).
27. Larman, H. B., Jing Xu, G., Pavlova, N. N. , Elledge, S. J. Construction of a rationally designed antibody platform for sequencingassisted selection. Proc Natl Acad Sci USA 109, 18523-18528 (2012).
28. Finlay, W. J. , Almagro, J. C. Natural and man-made V-gene repertoires for antibody discovery. Front Immunol 3, 342 (2012).
29. Prassler, J. et al. HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J Mol Biol 413, 261-278 (2011).
30. Ponsel, D., Neugebauer, J., Ladetzki-Baehs, K. , Tissot, K. High affinity, developability and functional size: the holy grail of combinatorial antibody library generation. Molecules 16, 3675-3700 (2011).
31. Hsu, H. J. et al. Antibody variable domain interface and framework sequence requirements for stability and function by highthroughput experiments. Structure 22, 22-34 (2014).
32. Chang, H. J. et al. Loop-sequence features and stability determinants in antibody variable domains by high-throughput experiments. Structure 22, 9-21 (2014).
33. Yu, C. M. et al. Rationalization and design of the complementarity determining region sequences in an antibody-antigen recognition interface. PLoS One 7, e33340 (2012).
34. Barbas, C. F., 3rd, Burton, D. R., Scott, J. K. , Silverman, G. J. in Phage Display A Laboratory Manual. Ch. 9, 9.1-9.113 (Cold Spring Harbor Press, Cold Spring Harbor, New York; 2001).
35. Andris-Widhopf, J., Steinberger, P., Fuller, R., Rader, C. , Barbas, C. F., 3rd Generation of human scFv antibody libraries: PCR amplification and assembly of light-and heavy-chain coding sequences. Cold Spring Harb Protoc 2011 (2011), doi: 10.1101/pdb. prot065573.
36. Almagro, J. C., Hernandez, I., del Carmen Ramirez, M. , Vargas-Madrazo, E. The differences between the structural repertoires of VH germ-line gene segments of mice and humans: implication for the molecular mechanism of the immune response. Mol Immunol 34, 1199-1214 (1997).
37. Chothia, C. et al. Structural repertoire of the human VH segments. J Mol Biol 227, 799-817 (1992).
38. Tomlinson, I. M., Cox, J. P., Gherardi, E., Lesk, A. M. , Chothia, C. The structural repertoire of the human V kappa domain. EMBO J 14, 4628-4638 (1995).
39. Chailyan, A., Marcatili, P., Cirillo, D. , Tramontano, A. Structural repertoire of immunoglobulin lambda light chains. Proteins 79, 1513-1524 (2011).
40. DeKosky, B. J. et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol 31, 166-169 (2013).
41. de Wildt, R. M., Hoet, R. M., van Venrooij, W. J., Tomlinson, I. M. , Winter, G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 285, 895-901 (1999).
42. Martin, A. C. , Thornton, J. M. Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. J Mol Biol 263, 800-815 (1996).
43. Raghunathan, G., Smart, J., Williams, J. , Almagro, J. C. Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens. J Mol Recognit 25, 103-113 (2012).
44. Zhou, H. et al. Structural insights into the down-regulation of overexpressed p185(her2/neu) protein of transformed cells by the antibody chA21. J Biol Chem 286, 31676-31683 (2011).
45. Fisher, R. D. et al. Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine. J Mol Biol 402, 217-229 (2010).
46. Sidhu, S. S. , Weiss, G. A. in Phage Display, Edn. 1st. (eds. T. Clackson & H. B. Lowman) Ch. 2, 27-41 (Oxford University Press, New York; 2004).
47. Chothia, C. et al. Conformations of immunoglobulin hypervariable regions. Nature 342, 877-883 (1989).